CS, N. (2016). Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes. Journal of diabetes research, 2016, 2846570. https://doi.org/10.1155/2016/2846570
Chicago Style (17th ed.) CitationCS, Nunemaker. "Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes." Journal of Diabetes Research 2016 (2016): 2846570. https://doi.org/10.1155/2016/2846570.
MLA (9th ed.) CitationCS, Nunemaker. "Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes." Journal of Diabetes Research, vol. 2016, 2016, p. 2846570, https://doi.org/10.1155/2016/2846570.